The immunomodulatory properties of viable Lactobacillus salivarius ssp. salivarius CECT5713 are not restricted to the large intestine

European Journal of Nutrition

Volumn 51, Issue 3, 2012, Pages 365-374

  Arribas, Belén ^a   Garrido Mesa, Natividad ^a   Perán, Laura ^a   Camuesco, Desirée ^b   Comalada, Mònica ^c   Bailón, Elvira ^a   Olivares, Mónica ^d   Xaus, Jordi ^a   Kruidenier, Laurens ^b   Sanderson, Ian R ^b   Zarzuelo, Antonio ^a   Rodríguez Cabezas, Maria Elena ^a   Gálvez, Julio ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^d Department of Immunology and Animal Sciences Biosearch Life ^*  (Spain)

Author keywords

Caco 2 cells; Cytokines; Immunoglobulin; Intestinal anti inflammatory activity; L. salivarius ssp. salivarius CECT5713; Mice LPS septic shock; TNBS rat colitis

Indexed keywords

GLUTATHIONE; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 5; INTERLEUKIN 8; PROBIOTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL VIABILITY; CELL DAMAGE; CELL REGENERATION; CELL STRAIN CACO 2; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG SCREENING; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; INTESTINE EPITHELIUM CELL; LACTOBACILLUS SALIVARIUS; LARGE INTESTINE; LIVER LEVEL; MOUSE; NONHUMAN; PROTEIN LOCALIZATION; RAT; SEPTIC SHOCK; SPLEEN CELL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CACO-2 CELLS; COLITIS; FEMALE; GLUTATHIONE; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; INTERLEUKIN-10; INTERLEUKIN-5; INTERLEUKIN-8; INTESTINAL MUCOSA; INTESTINE, LARGE; LACTOBACILLUS; LIPOPOLYSACCHARIDES; LIVER; MALE; MICE; MICE, INBRED BALB C; PROBIOTICS; RATS; RATS, WISTAR; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

LACTOBACILLUS SALIVARIUS; MUS; RATTUS;

EID: 84860667500     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-011-0221-4     Document Type: Article

References (34)

1. Boirivant M, Strober W (2007) The mechanism of action of probiotics. Curr Opin Gastroenterol 23:679-692 (Pubitemid 47508800)
2. Collado MC, Isolauri E, Salminen S, Sanz Y (2009) The impact of probiotic on gut health. Curr Drug Metab 10:68-78
3. Damaskos D, Kolios G (2008) Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'. Br J Clin Pharmacol 65:453-467 (Pubitemid 351365144)
4. Bernstein CN, Blanchard JF, Rawsthorne P, Yu N (2001) The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 96:1116-1122 (Pubitemid 32319146)
5. McCarthy J, O'Mahony L, O'Callaghan L et al (2003) Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 52:975-980 (Pubitemid 36765289)
6. Peran L, Camuesco D, Comalada M et al (2005) Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis. World J Gastroenterol 11:5185-5192 (Pubitemid 41410337)
7. Flynn S, van Sinderen D, Thornton GM, Holo H, Nes IF, Collins JK (2002) Characterization of the genetic locus responsible for the production of ABP-118, a novel bacteriocin produced by the probiotic bacterium Lactobacillus salivarius subsp. salivarius UCC118. Microbiology 148:973-984 (Pubitemid 34436774)
8. Olivares M, Díaz-Ropero MP, Martín R, Rodríguez JM, Xaus J (2006) Antimicrobial potential of four Lactobacillus strains isolated from breast milk. J Appl Microbiol 101:72-79 (Pubitemid 43952006)
9. Rachmilewitz D, Katakura K, Karmeli F et al (2004) Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126:520-528 (Pubitemid 38182309)
10. Strober W, Fuss IJ, Blumberg RS (2002) The immunology of mucosal models of inflammation. Annu Rev Immunol 20:495-549 (Pubitemid 34293433)
11. Dotan I, Allez M, Nakazawa A, Brimnes J, Schulder-Katz M, Mayer L (2007) Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-gamma. Am J Physiol Gastrointest Liver Physiol 292:G1630-G1640 (Pubitemid 47080586)
12. Camuesco D, Peran L, Comalada M et al (2005) Preventative effects of lactulose in the trinitrobenzenesulphonic acid model of rat colitis. Inflamm Bowel Dis 11:265-271 (Pubitemid 40439681)
13. Krawisz JE, Sharon P, Stenson WF (1984) Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87:1344-1350 (Pubitemid 15201434)
14. Anderson ME (1985) Determination of glutathione and glutathione disulfide in biological samples. Meth Enzymol 113:548-555 (Pubitemid 16195830)
15. Comalada M, Camuesco D, Sierra S, Ballester I, Xaus J, Gálvez J, Zarzuelo A (2005) In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway. Eur J Immunol 35:584-592 (Pubitemid 40331335)
16. Bailón E, Camuesco D, Nieto A et al (2007) The intestinal antiinflammatory effects of the novel agent UR-1505 in the TNBS model of rat colitis are mediated by T-lymphocyte inhibition. Biochem Pharmacol 74:1496-1506 (Pubitemid 47592842)
17. Shibolet O, Karmeli F, Eliakim R et al (2002) Variable response to probiotics in two models of experimental colitis in rats. Inflamm Bowel Dis 8:399-406 (Pubitemid 36411026)
18. Ma D, Forsythe P, Bienenstock J (2004) Live Lactobacillus reuteri is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Infect Immun 72:5308-5314 (Pubitemid 39223418)
19. Llopis M, Antolin M, Carol M et al (2009) Lactobacillus casei downregulates commensals' inflammatory signals in Crohn's disease mucosa. Inflamm Bowel Dis 15:275-283
20. Hisamatsu T, Ogata H, Hibi T (2008) Innate immunity in inflammatory bowel disease: state of the art. Curr Opin Gastroenterol 24:448-454
21. Lewis K, Caldwell J, Phan V et al (2008) Decreased epithelial barrier function evoked by exposure to metabolic stress and nonpathogenic E. coli is enhanced by TNF-αlpha. Am J Physiol Gastrointest Liver Physiol 294:G669-G678 (Pubitemid 351468760)
22. Díaz-Ropero MP, Martín R, Sierra S et al (2007) Two Lactobacillus strains, isolated from breast milk, differently modulate the immune response. J Appl Microbiol 102:337-343 (Pubitemid 46114999)
23. O'Hara AM, O'Regan P, Fanning A et al (2006) Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology 118:202-215 (Pubitemid 43727425)
24. Baharav E, Mor F, Halpern M, Weinberger A (2004) Lactobacillus GG bacteria ameliorate arthritis in Lewis rats. J Nutr 134:1964-1969 (Pubitemid 39031325)
25. So JS, Kwon HK, Lee CG et al (2008) Lactobacillus casei suppresses experimental arthritis by down-regulating T helper 1 effector functions. Mol Immunol 45:2690-2699
26. Isolauri E, Arvola T, Sütas Y, Moilanen E, Salminen S (2000) Probiotics in the management of atopic eczema. Clin Exp Allergy 30:1604-1610
27. Rosenfeldt V, Benfeldt E, Nielsen SD, Michaelsen KF, Jeppesen DL, Valerius NH, Paerregaard A (2003) Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 111:389-395 (Pubitemid 36228562)
28. Arribas B, Rodríguez-Cabezas ME, Comalada M et al (2009) Evaluation of the preventative effects exerted by Lactobacillus fermentum in an experimental model of septic shock induced in mice. Br J Nutr 101:51-58 (Pubitemid 352795581)
29. Arribas B, Rodríguez-Cabezas ME, Camuesco D et al (2009) A probiotic strain of Escherichia coli, Nissle 1917, given orally exerts local and systemic anti-inflammatory effects in lipopolysaccharide-induced sepsis in mice. Br J Pharmacol 157:1024-1033
30. Sheil B, McCarthy J, O'Mahony L et al (2004) Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis. Gut 53:694-700 (Pubitemid 38561448)
31. Annane D, Bellissant E, Cavaillon JM (2005) Septic shock. Lancet 365:63-78
32. Kim GY, Roh SI, Park SK, Ahn SC, Oh YH, Lee JD, Park YM (2003) Alleviation of experimental septic shock in mice by acidic polysaccharide isolated from the medicinal mushroom Phellinus linteus. Biol Pharm Bull 26:1418-1423
33. Damaskos D, Kolios G (2008) Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'. Br J Clin Pharmacol 65:453-467 (Pubitemid 351365144)
34. Arad G, Hillman D, Levy R, Kaempfer R (2004) Broad-spectrum immunity against superantigens is elicited in mice protected from lethal shock by a superantigen antagonist peptide. Immunol Lett 91:141-145 (Pubitemid 38296371)